Kronos Bio, Inc. (KRON)
NASDAQ: KRON · IEX Real-Time Price · USD
1.260
+0.020 (1.61%)
Mar 28, 2024, 9:53 AM EDT - Market open

Kronos Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Revenue
6.2900000
Gross Profit
6.2900000
Selling, General & Admin
41.7443.438.514.793.371.61
Research & Development
86.3893.72112.943.2513.455.03
Operating Expenses
128.12137.12151.458.0416.826.65
Operating Income
-121.83-137.12-151.4-58.04-16.82-6.65
Interest Expense / Income
0003.8900.08
Other Expense / Income
-9.16-3.91-0.3226.51-0.7-
Pretax Income
-112.67-133.2-151.08-88.44-16.12-6.72
Net Income
-112.67-133.2-151.08-88.44-16.12-6.72
Shares Outstanding (Basic)
5856551655
Shares Outstanding (Diluted)
5856551655
Shares Change
2.75%2.64%236.38%208.35%8.69%-
EPS (Basic)
-1.95-2.37-2.76-5.43-3.05-1.38
EPS (Diluted)
-1.95-2.37-2.76-5.43-3.05-1.38
Free Cash Flow
-79.26-91.5-122.18-47.48-18.03-7.52
Free Cash Flow Per Share
-1.37-1.63-2.23-2.92-3.42-1.55
Gross Margin
100.00%-----
Operating Margin
-1937.50%-----
Profit Margin
-1791.87%-----
Free Cash Flow Margin
-1260.51%-----
EBITDA
-107.76-128.74-147-79.69-15.51-6.49
EBITDA Margin
-1713.69%-----
Depreciation & Amortization
4.924.464.084.870.610.16
EBIT
-112.67-133.2-151.08-84.55-16.11-6.65
EBIT Margin
-1791.87%-----
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).